-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Current State and Anticipated Barriers in Increasing DEI in Hematology Clinical Trials

Symposia: Scientific Workshop on Defining Goals and Utilizing Tools for Enhancing Diversity, Equity and Inclusion (DEI) in Clinical Trials in Hematology Program: Scientific Workshops
Friday, December 8, 2023: 2:05 PM-3:00 PM
Room 33 (San Diego Convention Center)
Moderators:
Fangxin Hong, PhD, Pfizer and Raul Cordoba, MD, PhD, Fundacion Jimenez Diaz University Hospital
Disclosures:
Hong: Pfizer Inc.: Current Employment.
Moderator Introduction

Arushi Khurana, MBBS

Mayo Clinic, Rochester, MN
DEI in Clinical Trials: Where Are We Now and Where We Should Strive to be?

Ruemu E. Birhiray, MD

Hematology Oncology of Indiana, PC, Indianapolis, IN
DEI in Clinical Trials - Perceived Versus Actual Barriers and How to Address Them: Clinical Investigator Perspective

Thomas E. Witzig, MD

Mayo Clinic, Rochester, MN
DEI in Clinical Trials - Perceived Versus Actual Barriers and How to Address Them: Industry Perspective

Ahmed Abd Almalik Daak, MD, PhD, MSc, DPM/MFPM

Clinical Development- Rare Blood Disorders, Sanofi, Concord, MA
Panel Discussion
See more of: Scientific Workshop on Defining Goals and Utilizing Tools for Enhancing Diversity, Equity and Inclusion (DEI) in Clinical Trials in Hematology
See more of: Scientific Workshops
<< Previous Session | Next Session >>